eISSN: 2345-6558

Free Access

2016, Volume 4, Issue 1,

 Editorial pp. 1 - 2  
  An update on sclerostin and kidney
  Hamid Nasri
 PDF      XML      Abstract     
 Original pp. 3 - 6  
  Effect and safety of alendronate on bone density in patients with chronic kidney disease; a controlled double blind randomized clinical trial
  Heshmatollah Shahbazian, Mohammad-Reza Tamadon, Seyed Karim Mowla, Shokouh Shayanpour, Fatemeh Hayati, Melika Shojaii, Leila Yazdanpanah
 PDF      XML      Abstract     
 Original pp. 7 - 10  
  Correlation of fibroblast growth factor 23 in chronic kidney disease patients with biochemical parameters and outcomes
  Anand Yuvaraj, Georgi Abraham, Madhusudan Vijayan, Jayaraju Jayapal, Saranya Kulanthaipandian, Sanjeev Nair
 PDF      XML      Abstract     
 Commentary pp. 11 - 12  
  Fibroblast growth factor 23 and cardiovascular events in chronic kidney disease patients
  Fatemeh Yaghoubi
 PDF      XML      Abstract     
 Mini-Review pp. 13 - 16  
  Maxillofacial radiographic changes in renal osteodystrophy
  Atul Kaushik, Monika Kaushik
 PDF      XML      Abstract     
 Mini-Review pp. 17 - 19  
  Estimation of annual per capita treatment in osteoporosis
  Saleh Khodadadi, Samaneh Khodadadi
 PDF      XML      Abstract     
 Mini-Review pp. 20 - 24  
  Vitamin D and its importance on public health
  Shiva Borji, Mahmoud Rafieian-Kopaei
 PDF      XML      Abstract     
 Review pp. 25 - 30  
  Vitamin D and chronic kidney disease
  Fatemeh Hayati, Mohammad Amin Nasouti, Shokhouh Shayanpour, Shahla Ahmadi Halili, Hossain Karimpourian, Zarrin Beladi Mousavi
 PDF      XML      Abstract     
 Mini-Review pp. 31 - 33  
  Pulmonary hypertension and deficiency of vitamin D
  Sara Beigrezaei, Hamid Nasri
 PDF      XML      Abstract     
Creative Commons Attribution 4.0 License This work is licensed under a Creative Commons Attribution 4.0 License.
Copyright © 2016 The Author(s)
Published by Nickan Research Institute